Hook & thesis
Peter Thiel reduced his stake in Palantir. It makes for an attention-grabbing headline, but the facts on the ground argue that this may be early. Palantir’s software sits at the intersection of defense, intelligence and enterprise AI — precisely the markets with accelerating budget tails today. Recent wins, strong margin conversion and a healthy free cash flow profile give the company both runway and optionality.
That said, the market has already priced in a lot. The shares trade at eye‑watering multiples: a price/earnings north of 220, price/sales of roughly 82 and price/book near 49. This isn’t a value play; it’s a growth‑at‑scale wager. My trade idea: buy the stock on weakness around the current price to capture near‑term upside as geopolitical and procurement catalysts crystallize, but protect capital with a disciplined stop to respect valuation risk.
What Palantir does and why the market should care
Palantir builds enterprise-scale data integration and analytics platforms used by government agencies and commercial customers. Its products are positioned as operational decision systems — stitching large, messy datasets into actionable intelligence for defense, health, energy and financial services. The company operates two segments: Government and Commercial. Government still accounts for a meaningful portion of revenue, but commercial adoption is accelerating.
Why that matters: governments tend to provide durable, high‑value contracts and scale opportunities; commercial customers provide growth and margin expansion if Palantir can move beyond early adopters to broad deployment across Fortune‑scale accounts. In the current macro, both drivers have tailwinds: defense budgets tied to geopolitical tensions and corporate investment to operationalize AI.
What the numbers show
- Market cap: roughly $365 billion and enterprise value around $363.7 billion.
- Valuation: price/earnings around 225, price/sales ~81.6, price/book ~49.4 and EV/EBITDA ~252.6. These multiples demand continued high growth.
- Profitability and cash generation: trailing free cash flow was about $2.10 billion, return on assets ~18.3% and return on equity ~22.0% — healthy operating returns for a software company.
- Balance sheet: current ratio ~7.11 and reported debt/equity of 0 — a very strong liquidity position to fund investments or M&A.
- Operational momentum from recent reporting: revenue growth metrics running in the high‑double digits to triple digits in parts of the business. One analysis highlighted 70% year‑over‑year revenue growth and 79% earnings growth in the most recent quarter; U.S. commercial revenue was cited as growing 137% year‑over‑year in one quarter. Government domestic sales highlighted 66% year‑over‑year growth in Q4, which keeps the defense angle on track.
- Trading and technicals: the stock recently traded near $153 with 10‑day and 20‑day SMAs around $140 and $137, while the 50‑day SMA sits near $158. RSI sits in neutral‑to‑slightly bullish territory (~57) and MACD shows bullish momentum.
Valuation framing
There are two ways to look at Palantir’s valuation. Optimistically, the multiples make sense if the company sustains very high growth for several years, scales margins further and converts commercial trials into multi‑hundred‑million dollar accounts. The company’s reported operating metrics and cash flow support that possibility: strong FCF and operating returns give management flexibility to reinvest and capture bigger commercial accounts.
On the other hand, the stock trades like a near‑perfect execution story with little room for missteps: >200x earnings and >80x sales leaves zero margin for error. Even small growth disappointments could prompt big multiple compression. That dichotomy is why Thiel’s exit matters psychologically — it reduces a perceived anchor of patient capital even as fundamentals look strong.
Catalysts to push the stock higher
- Geopolitical escalation or renewed focus on defense procurement: recent headlines linking Palantir to U.S. and allied military operations can accelerate contract wins and renewals.
- Regulatory or policy shifts that limit competitor access to government work. For example, a government decision affecting an Anthropic-type competitor can create near‑term deal flow for Palantir.
- Quarterly results showing continued high‑teens to double‑digit revenue growth with margin expansion and continued commercial conversion (large multi‑year deals).
- Major customer expansions in commercial verticals cited in recent reporting (energy, retail, finance) that validate platform stickiness and drive multi‑year revenue visibility.
Trade plan (actionable):
Thesis: Buy Palantir to capture upside from contract and AI adoption momentum while capping downside with a strict stop because valuation is already very elevated.
| Entry | Stop | Target | Direction | Horizon |
|---|---|---|---|---|
| $153.00 | $125.00 | $220.00 | Long | Mid term (45 trading days) |
Rationale: entering at $153 buys the recent consolidation after a strong run. The $125 stop respects the valuation risk — if the stock falls below that level it likely signals a re‑rating. The $220 target is achievable if the company prints another strong quarter or if a near‑term catalyst (contract wins, policy shifts) removes investor uncertainty. This trade is for mid term (45 trading days) because catalysts (contract awards, policy shifts, or quarterly results) are most likely to show through within ~two months while allowing time for momentum to build.
Position sizing: given the valuation risk, allocate a modest portion of risk capital (e.g., 1–3% of portfolio) and consider scaling in on pullbacks toward the 20–50 day SMA band. Monitor short interest (days to cover roughly 1), volume spikes and headline risk closely.
Risks and counterarguments
- Valuation sensitivity: the stock trades at >200x earnings and >80x sales. Any slowdown in revenue growth or margin contraction risks significant multiple compression.
- Concentration and procurement risk: government work can be lumpy and subject to political and contracting cycles. A loss of a major government contract or delays in awards would materially impact near‑term growth.
- Competition and platform risk: established cloud providers and emerging AI specialists could erode pricing power or win key deals, especially in commercial accounts.
- Macro/liquidity risk: a broader tech selloff or rotation away from high‑multiple AI names could push the stock well below the stop if liquidity dries up.
- Insider/psychology risk: large insider sales — such as Thiel’s — can shift investor sentiment and increase volatility even if fundamentals remain intact.
Counterargument: Critics can point to sell ratings and price targets a long way below current levels; some analysts argue the current valuation requires multi‑year perfection in execution. That argument is valid — if growth decelerates toward mid‑teens and commercial conversion stalls, those low targets look reasonable. This trade therefore relies on continued execution and policy/geopolitical catalysts to keep multiple expansion on the table.
What would change my mind
I would rethink the bullish stance if any of the following occur: a) sequential revenue growth slows materially below the company’s recent trends, b) margins begin to compress meaningfully, c) Palantir loses a material government contract or faces regulatory barriers to government work, or d) we see decisive evidence that commercial adoption is stalling (failed large implementations or large customer churn). Conversely, sustained acceleration in commercial ARR conversions, multi‑year enterprise renewals and evidence of durable pricing power would make me more aggressive and extend the horizon toward long term (180 trading days).
Bottom line
Peter Thiel’s decision to sell may feel symbolic, but Palantir’s core business trends still argue for respect: strong revenue growth in multiple pockets, solid margin conversion and meaningful free cash flow give the company optionality. The market has already priced a lot of optimism, so this is not a blind buy — it’s a traded conviction. The proposed mid‑term long with a $125 hard stop and a $220 target allows you to capture near‑term upside while limiting downside if the market re‑rates the name.
Key next checkpoints to watch
- New contract announcements and official government procurement updates.
- Quarterly results showing sustained double‑digit revenue growth and margin expansion.
- Any policy or administrative actions that affect competitor access to government contracts.
- Volume and short interest shifts — look for rising institutional uptake or a change in days to cover as sentiment shifts.
Trade idea: Long PLTR at $153.00, stop $125.00, target $220.00. Mid term (45 trading days). Risk: medium‑high.